Oxaliplatin-based second-line chemotherapy in neuroendocrine carcinomas. A case series and review of the literature. (2016). European Journal of Oncology and Environmental Health, 21(2), 123-129. https://mattioli1885journals.com/index.php/EJOEH/article/view/4362